etiocholanolone has been researched along with Pituitary Neoplasms in 2 studies
Etiocholanolone: The 5-beta-reduced isomer of ANDROSTERONE. Etiocholanolone is a major metabolite of TESTOSTERONE and ANDROSTENEDIONE in many mammalian species including humans. It is excreted in the URINE.
3alpha-hydroxy-5beta-androstan-17-one : An androstanoid that is 5beta-androstane substituted by an alpha-hydroxy group at position 3 and an oxo group at position 17. It is a metabolite of testosterone in mammals.
Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with bromocriptine caused a decrease in the E/A ratio in patients with decreased growth hormone levels, but not in patients in whom the growth hormone level remained unchanged." | 5.27 | The influence of bromocriptine and transsphenoidal surgery on urinary androgen metabolite excretion in acromegaly. ( Frölich, M; Moolenaar, AJ; Roelfsema, F, 1984) |
| "We describe a female child with pituitary gigantism and precocious adrenarche." | 2.38 | A child with pituitary gigantism and precocious adrenarche: does GH and/or PRL advance the onset of adrenarche? ( Iwatani, N; Kodama, M; Seto, H, 1992) |
| "Treatment with bromocriptine caused a decrease in the E/A ratio in patients with decreased growth hormone levels, but not in patients in whom the growth hormone level remained unchanged." | 1.27 | The influence of bromocriptine and transsphenoidal surgery on urinary androgen metabolite excretion in acromegaly. ( Frölich, M; Moolenaar, AJ; Roelfsema, F, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roelfsema, F | 1 |
| Moolenaar, AJ | 1 |
| Frölich, M | 1 |
| Iwatani, N | 1 |
| Kodama, M | 1 |
| Seto, H | 1 |
1 review available for etiocholanolone and Pituitary Neoplasms
| Article | Year |
|---|---|
A child with pituitary gigantism and precocious adrenarche: does GH and/or PRL advance the onset of adrenarche?
Topics: Adenoma; Adrenal Cortex; Androgens; Child; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; D | 1992 |
1 other study available for etiocholanolone and Pituitary Neoplasms
| Article | Year |
|---|---|
The influence of bromocriptine and transsphenoidal surgery on urinary androgen metabolite excretion in acromegaly.
Topics: Acromegaly; Adenoma, Acidophil; Androgens; Androsterone; Bromocriptine; Dehydroepiandrosterone; Etio | 1984 |